Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

trilostane

A synthetic derivative of androstane with adrenocortical suppressive properties. Trilostane reversibly inhibits 3 beta-hydroxysteroid dehydrogenase delta 5-4 isomerase in the adrenal cortex, resulting in the decreased synthesis of mineralocorticoids and glucocorticoids and the decreased conversion of pregnenolone to progesterone.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
US brand name:Modrastane
Foreign brand name:Desopan
Modrenal
Code name:WIN 24,540
WIN 24540
Chemical structure:(4Alpha,5alpha,17beta)-4,5-epoxy-3,17-dihydroxyandrost-2-ene-2-carbonitrile
2Alpha-cyano-4alpha,5alpha-epoxyandrostan-17beta-ol-3-one
4,5-Epoxy-17-hydroxy-3-oxoandrostane-2-carbonitrile
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search